Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | -44,994 | 230 | 232 | 181 | 0 |
| Operating Income | 44,994 | -230 | -232 | -181 | N/A |
| Interest Expense | 14 | 280 | 260 | 251 | 0 |
| Other Income | -45,158 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -178 | -509 | -492 | -432 | 0 |
| Net Income Continuous | -178 | -509 | -492 | -432 | N/A |
| Net Income | $-178 | $-509 | $-492 | $-432 | $N/A |
| EPS Basic Total Ops | 33.63 | -40.84 | -40.84 | -36.04 | N/A |
| EPS Basic Continuous Ops | 33.06 | -42.03 | -40.60 | -35.63 | N/A |
| EPS Diluted Total Ops | 33.63 | -40.84 | -40.84 | -36.04 | N/A |
| EPS Diluted Continuous Ops | 33.06 | -42.03 | -40.60 | -35.63 | N/A |
| EBITDA(a) | $44,994 | $-230 | $-232 | $-181 | $N/A |